S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Options trading has suddenly become more reliable. (Ad)
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
The "Smart Money" Is Ready for May 1st Are You? (Ad)
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
A.I. Pioneer Issues Urgent Warning to Americans (Ad)
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Options trading has suddenly become more reliable. (Ad)
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
The "Smart Money" Is Ready for May 1st Are You? (Ad)
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
A.I. Pioneer Issues Urgent Warning to Americans (Ad)
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Options trading has suddenly become more reliable. (Ad)
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
The "Smart Money" Is Ready for May 1st Are You? (Ad)
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
A.I. Pioneer Issues Urgent Warning to Americans (Ad)
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Options trading has suddenly become more reliable. (Ad)
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
The "Smart Money" Is Ready for May 1st Are You? (Ad)
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
A.I. Pioneer Issues Urgent Warning to Americans (Ad)
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
Free Trial
NASDAQ:MLND

Millendo Therapeutics (MLND) Stock Price, News & Analysis

→ Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad)
Free MLND Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$3.31
▼
$3.63
50-Day Range
$3.06
▼
$5.84
52-Week Range
$0.92
▼
$16.95
Volume
586,820 shs
Average Volume
1.52 million shs
Market Capitalization
$63.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisCompetitorsSocial Media
MLND stock logo

About Millendo Therapeutics Stock (NASDAQ:MLND)

As of June 25, 2021, Millendo Therapeutics, Inc. was acquired by Tempest Therapeutics Inc., in a reverse merger transaction. Millendo Therapeutics, Inc. operates as a biopharmaceutical company. The company is headquartered in Ann Arbor, Michigan.

MLND Stock News Headlines

March 20, 2024 | msn.com
A lifesaving therapy for children with a rare disease is now the world’s most expensive drug, raising questions about access
March 7, 2024 | msn.com
Mind Medicine sends psychedelic stocks higher after FDA status for LSD formulation
April 16, 2024 | InvestorPlace (Ad)
Elon Musk’s ChatGPT Could Soon Mint New Millionaires
Elon Musk made $180 million on PayPal… $47 Billion on SpaceX…and $94.2 Billion on Tesla. He’s about to shock the world again with his version of ChatGPT.
January 11, 2024 | markets.businessinsider.com
Clearmind Medicine Inc. Announces Pricing of $2.4 Million Registered Direct and Private Placement
December 5, 2023 | msn.com
Why Is Clearmind Medicine (CMND) Stock Up 50% Today?
November 6, 2023 | markets.businessinsider.com
Maxim Group Maintains Their Buy Rating on Mind Medicine (MMED)
March 15, 2023 | benzinga.com
Expert Ratings for Decibel Therapeutics
December 29, 2022 | insidermonkey.com
Iterum Therapeutics plc (NASDAQ:ITRM) Q3 2022 Earnings Call Transcript
April 16, 2024 | InvestorPlace (Ad)
Elon Musk’s ChatGPT Could Soon Mint New Millionaires
Elon Musk made $180 million on PayPal… $47 Billion on SpaceX…and $94.2 Billion on Tesla. He’s about to shock the world again with his version of ChatGPT.
December 29, 2022 | yahoo.com
Clearmind Medicine Announces Shareholders Meeting Results
June 3, 2022 | finance.yahoo.com
Clearmind Medicine Granted Patent Approval for Psychedelic- Based Alcohol Substitute in India
May 31, 2022 | finance.yahoo.com
DTx Pharma Appoints Michael Huang, MD as Chief Medical Officer
May 19, 2022 | finance.yahoo.com
Clearmind Medicine Announces Successful Pre-Clinical Results in MEAI Treatment for Alcohol Consumption
May 16, 2022 | seekingalpha.com
Mind Medicine(MNMD) CEO Rob Barrow on Q1 2022 Results - Earnings Call Transcript
May 15, 2022 | finance.yahoo.com
Clearmind Announces Pre-IND Meeting Date with FDA
See More Headlines
Receive MLND Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Millendo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:MLND
CUSIP
N/A
CIK
N/A
Web
www.millendo.com
Phone
734 845 9000
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-36,410,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-91.03%
Return on Assets
-72.44%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.39
Quick Ratio
6.39

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.78 per share
Price / Book
1.88

Miscellaneous

Outstanding Shares
19,043,000
Free Float
N/A
Market Cap
$63.60 million
Optionable
Not Optionable
Beta
0.48
7 Stocks to Buy And Hold Forever Cover
7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

MLND Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Millendo Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Millendo Therapeutics investors own include Allena Pharmaceuticals (ALNA), Matinas BioPharma (MTNB), VYNE Therapeutics (VYNE), Acasti Pharma (ACST), Onconova Therapeutics (ONTX), TherapeuticsMD (TXMD), Bionano Genomics (BNGO), DURECT (DRRX), Geron (GERN) and Heat Biologics (HTBX).

This page (NASDAQ:MLND) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
The #1 Crypto for 2024
InvestorPlace
Options trading has suddenly become more reliable.
Eagle Publishing
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
[BUY ALERT] Our #1 A.I. Stock for April
Behind the Markets